The page cannot be displayed because you are using Internet Explorer version 8 or lower.

Please consider upgrading your browser here

We use cookies on this website. By using the website you accept our use of cookies. Accept


Danish Diabetes Academy

The ambition of the Danish Diabetes Academy is to train the future generation of diabetes researchers to adopt intersectoral and interdisciplinary approaches to their work. The overall purpose is to enable researchers to develop new types of treatment of diabetes.


Allan Flyvbjerg, Professor, Chair of the Academy.

In search of a cure

Diabetes is a chronic disease, and the prevalence is constantly increasing in Denmark and elsewhere. An estimated 425 million people have diabetes globally.

The Academy aims to improve the quality of diabetes research in Denmark and to provide an overall view of diabetes research in the country. The Academy attracts the best researchers from Denmark and elsewhere and creates a collaborative culture of networking and knowledge-sharing between the participating researchers. The Academy also aims to ensure the future of diabetes research by offering several new research positions and schemes targeting young talented researchers, who will achieve optimal opportunities to improve their capabilities and pursue a career within this field.

The Academy's overall aim is to generate new knowledge on diabetes and new ways of treating and preventing it.

Platform for collaboration

The core of the Academy is the secretariat located at Odense University Hospital, which is hosting the Academy, but the participating researchers are employed at various universities and hospitals throughout Denmark. One of the main tasks of the administration is to create a platform for collaboration between researchers through such means as courses and conferences. The Academy is open to all diabetes researchers in Denmark and elsewhere who wish to accept the Academy’s offerings. The vision is that this collaboration across faculties and frontiers will create a synergy effect that will strengthen research in Denmark and globally.

The Academy is a spin-off of another initiative supported by the Foundation: the Danish PhD School of Molecular Metabolism, which offers PhD scholarships for research on such subjects as diabetes and obesity. The Foundation has awarded grants to the School of DKK 13.5 million (2008–2010) and DKK 25 million (2010–2013).

In 2012, the Foundation awarded a grant of DKK 201 million (€26.9 million) over 5 years to Odense University Hospital to establish the Academy. In 2017, the Foundation awarded an additional grant of DKK 156 million to the Academy.


News room

Novo Nordisk Foundation awards DKK 156 million to the Danish Diabetes Academy

Friday, 12 January 2018

The Foundation is awarding the grant to the Danish Diabetes Academy to educate the next generation of diabetes researchers and to support networking and research collaboration. The goal is to...